MedTrace Logo

Screening Tool to Identify the Dominant Pain Mechanism in Cancer Survivors: PainsCan

NCT03981809 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2023-08-22

No results posted yet for this study

Summary

Development and internal validation of an easy-to-use tool for clinical pain assessment. The tool has to be applicable in any clinical practice and without the need for expensive and complicated hospital tools to identify the source of persistent pain after the treatment of cancer.

Conditions

  • Cancer Survivors
  • Cancer Pain

Interventions

DIAGNOSTIC_TEST

Diagnostic test ("PainsCan") for the identification of the dominant pain mechanisms in cancer survivers with persistent pain

Easy-to-use screening tool to identify the dominant pain mechanism by using quick clinical tests and compare their accuracy and validity with complicated reference tests.

Sponsors & Collaborators

  • Fund for Scientific Research, Flanders, Belgium

    collaborator OTHER

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Nele Devoogdt, Prof. · UZ Leuven

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-13
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03981809 on ClinicalTrials.gov